Innovation Medical Management Co., Ltd.

Sümbol: 002173.SZ

SHZ

8.86

CNY

Turuhind täna

-107.2347
P/E suhe
0.1986
PEG suhe
3.91B
MRK Cap
0.00%
DIV tootlus

Innovation Medical Management Co., Ltd. (002173-SZ) Finantsaruanded

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Innovation Medical Management Co., Ltd. (002173.SZ) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 483.51 M, mis on 0.134 % gowth. Kogu perioodi keskmine brutokasum on 115.05 M, mis on 0.199 %. Keskmine brutokasumi suhtarv on 0.262 %. Ettevõtte eelmise aasta tulemuse puhaskasv on -0.536 %, mis on võrdne -2.722 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Innovation Medical Management Co., Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus -0.025. Käibevara valdkonnas on 002173.SZ aruandlusvaluutas 733.059. Märkimisväärne osa neist varadest, täpsemalt 583.16, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust -0.114%. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 20.327 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on 0.173%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 1870.152 aruandlusvaluutas. Selle aspekti aastane muutus on -0.018%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 106.972, varude hind on 41.81 ja firmaväärtus 0.99, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 129.56.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004
balance-sheet.row.cash-and-short-term-investments	2371.68	583.2	658.5	799.8	939.8	940.7	618.3	560.8	1334.3	98.6	23.6	41.3	64.2	32.7	35.5	63.8	39.4	101.8	55.1	15	13.2
balance-sheet.row.short-term-investments	-32.02	20.1	0	574	593.5	61.4	45.5	0	-18.6	-14.7	0	0	-5.8	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	410.45	107	60.9	94.3	135.1	225.1	423.5	293	215.5	91	139.4	167.3	153.4	163	149.3	154.2	153.1	113.2	103.8	69.1	29.4
balance-sheet.row.inventory	157.59	41.8	49.3	43	34.5	53.5	48.8	729.1	757.5	729.9	715.3	667.3	616.1	568.3	530.1	470.2	385.6	323.3	170.4	134.8	78.6
balance-sheet.row.other-current-assets	8.09	1.1	3	2.9	10.6	8.3	638.5	786.9	1	1	1.1	-2.3	1.3	-5	-7	-4.4	-3.1	-2.8	-12.6	-6.6	-4.1
balance-sheet.row.total-current-assets	2947.81	733.1	771.6	940	1120	1227.7	1728.9	2369.8	2308.2	920.5	879.4	873.6	835	759	708	683.8	575.1	535.6	316.6	212.3	117.1
balance-sheet.row.property-plant-equipment-net	5372.28	1349.8	1375.5	1397	1390.3	1392.4	1274	1035.6	982.4	86.6	97.7	103.9	81.3	52.3	52	51.8	53.1	39	32.6	29	20
balance-sheet.row.goodwill	3.95	1	1	1	0	127	1018	1016.3	1016.3	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	502.52	129.6	121.8	125.2	128.7	132	123.1	131.2	134.4	34.1	41.4	50.2	74.4	76.1	53.7	26.1	18.7	19.8	21.2	9.4	6.8
balance-sheet.row.goodwill-and-intangible-assets	506.47	130.5	122.8	126.2	128.7	259	1141.1	1147.5	1150.7	34.1	41.4	50.2	74.4	76.1	53.7	26.1	18.7	19.8	21.2	9.4	6.8
balance-sheet.row.long-term-investments	94.5	-4.9	17.9	-554.3	22.6	28.9	0	0	41	18.2	0	0	9.3	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	59.97	17	14.4	13.8	8.4	30.5	13.5	20.8	21.1	13.5	13.9	13.6	12.4	8.7	5.9	2.4	1.5	1.4	2.8	1	0.3
balance-sheet.row.other-non-current-assets	117.43	55.9	37.4	633.5	7.5	29.6	107.7	76.4	63.6	0.2	8.5	10	0.5	9.5	8.8	9.4	8.7	5.4	2.3	1.5	0
balance-sheet.row.total-non-current-assets	6150.64	1548.4	1568	1616.2	1557.6	1740.4	2536.3	2280.3	2258.8	152.6	161.4	177.6	177.9	146.6	120.3	89.6	82	65.5	58.9	40.8	27.2
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	9098.45	2281.5	2339.7	2556.2	2677.5	2968	4265.3	4650.2	4567	1073.1	1040.8	1051.2	1012.9	905.6	828.3	773.5	657.1	601.1	375.6	253.1	144.3
balance-sheet.row.account-payables	766.16	208.1	210.1	183.4	180.5	166.6	99.6	87.1	90.2	13.9	27.8	28.8	11.3	19.4	21.4	44.3	25.4	34.6	42.6	5.2	8
balance-sheet.row.short-term-debt	157.13	48.2	36.9	29.9	52.5	56.6	294	266	263.2	445.8	464.6	352	324.1	375.2	335	306.6	214.9	186.9	156.6	136.8	43
balance-sheet.row.tax-payables	18.08	6.6	5.8	5.9	7.5	8.9	20.8	67	57.8	32.7	33.1	30	27.5	26.9	19.9	5.3	1.7	-11.6	-3.6	-7.9	-2.7
balance-sheet.row.long-term-debt-total	80.78	20.3	21.6	33.9	9	39	66.5	42.4	84.9	4.8	4.8	100	100	0	0	0	0	0	10	0	0
Deferred Revenue Non Current	16.99	4.2	4.8	5.2	5.8	3.6	4.4	5.2	6	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	177.64	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	58.66	0	70.1	46	29.7	6.1	84.6	532.7	9.6	4	16.5	9.7	1.7	1.9	2.5	2.8	14.3	33.9	31	13.8	10.6
balance-sheet.row.total-non-current-liabilities	338.5	85	112	219.3	174.7	182.3	170.5	108.3	240.3	4.9	4.8	109.4	109.4	0.1	0.1	0.1	0.1	0	10	0	0
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	80.78	20.3	21.6	33.9	44.6	22.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	1566.11	410.4	434.4	565.3	533.1	498.1	648.7	994.2	1035	659.7	562.2	549.7	492.7	439.6	393.9	369.6	265.5	251.2	241.4	150.8	62.2
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	1800.21	449	453.1	453.6	454.9	454.9	454.9	456	456.9	202.2	205	205	205.5	201	100.5	100.5	67	67	50	50	50
balance-sheet.row.retained-earnings	-5168.47	-1304.2	-1269.7	-1184.2	-1079	-764.4	382.4	398.3	257.6	142.8	208.2	219	205	181.1	153.3	127.6	117.5	83	45.8	24.3	12.8
balance-sheet.row.accumulated-other-comprehensive-income-loss	2861	43.8	43.4	40.1	32.3	43.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	8035.94	2681.5	2677.5	2680.3	2735.2	2735.2	2778.6	2801.2	2817.1	68.3	65.4	77.5	67.7	42.4	141.1	138.7	170.8	169.2	14.7	10.9	7.7
balance-sheet.row.total-stockholders-equity	7528.69	1870.2	1904.3	1989.8	2143.4	2469	3615.9	3655.5	3531.6	413.4	478.6	501.5	478.2	424.5	394.9	366.7	355.3	319.2	110.5	85.2	70.4
balance-sheet.row.total-liabilities-and-stockholders-equity	9098.45	2281.5	2339.7	2556.2	2677.5	2968	4265.3	4650.2	4567	1073.1	1040.8	1051.2	1012.9	905.6	828.3	773.5	657.1	601.1	375.6	253.1	144.3
balance-sheet.row.minority-interest	3.65	0.9	0.9	1.1	1	0.9	0.7	0.4	0.4	0	0	0	42	41.5	39.4	37.1	36.3	30.7	23.7	17.1	11.7
balance-sheet.row.total-equity	7532.33	1871.1	1905.2	1990.9	2144.4	2469.9	3616.5	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	9098.45	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	62.48	15.2	17.9	19.8	593.5	61.4	45.5	18.7	22.4	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	0	0	0	0
balance-sheet.row.total-debt	237.91	68.5	58.4	63.8	61.5	95.6	360.5	308.4	348.1	450.7	469.4	452	424.1	375.2	335	306.6	214.9	186.9	166.6	136.8	43
balance-sheet.row.net-debt	-2093.02	-494.5	-600.1	-161.9	-284.7	-783.6	-212.3	-252.4	-986.2	352.1	445.7	410.7	359.9	342.5	299.5	242.8	175.5	85.1	111.5	121.8	29.8

Rahavoogude aruanne

Innovation Medical Management Co., Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab 0.423 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 0, mis tähistab -0.891 erinevust võrreldes eelmise aastaga. Huvitav on see, et osa ettevõtte aktsiatest, täpsemalt 0, ostis ettevõte ise tagasi. Selle tegevuse tulemusena muutus 0.000 võrreldes eelmise aastaga. Vahepeal on ettevõtte võlgnevused praegu 2.39 aruandlusvaluutas. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli -415340829.270. See on -1.903 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 106.66, 0.9, -23, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte -1.46 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui -10.51, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004
cash-flows.row.net-income	-35.11	-34.3	-73.9	-105.1	-314.4	-1149.8	29.9	140.8	114.8	-65.3	-10.8	24.7	38.6	32.1	31.1	12.7	42.9	40	30.3	18.4	20.8
cash-flows.row.depreciation-and-amortization	6.63	106.7	110.3	117.5	111.8	104.4	94.7	92.5	83.3	9	8.2	7.8	7.4	6.2	5.9	5.6	5.2	4.3	3.7	1.4	0.7
cash-flows.row.deferred-income-tax	0	-3.2	-1.4	-3.9	21.4	-18	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	3.2	1.4	3.9	-21.4	18	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-79.95	-43	9.8	18.9	138	76.2	-140.5	-38.4	7.3	57.5	-12.7	-63.6	-57.6	-74.2	-45	-74.6	-129.3	-154	-46.9	-102.4	-29
cash-flows.row.account-receivables	-49.07	-49.1	36	11.7	60	61.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	6.82	6.8	-6.7	-8	17.2	-4.8	0.4	10.8	-15	-14.6	-48	-51.2	-47.8	-38.2	-59.9	-84.6	-62.3	-152.9	-35.6	-56.2	-21.5
cash-flows.row.account-payables	0	2.4	-18.1	19.1	39.4	37.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	-37.7	-3.2	-1.4	-3.9	21.4	-18	-140.9	-49.1	22.3	72.1	35.3	-12.4	-9.8	-36.1	15	10	-67	-1.1	-11.3	-46.2	-7.6
cash-flows.row.other-non-cash-items	89.42	-18.3	-70.7	12	196.3	1065.5	145.3	11.2	44.8	32.3	25.9	35.4	40.8	26.4	17.5	17.2	21.5	11.9	16.4	9.1	2.4
cash-flows.row.net-cash-provided-by-operating-activities	-19.01	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-90.18	-96.2	-123.2	-110.7	-108.4	-160.5	-399.9	-164.6	-181	-3.8	-16.7	-28.2	-28.1	-9.8	-49.7	-13	-9.3	-13.8	-9.1	-14.4	-6.8
cash-flows.row.acquisitions-net	0.13	0.3	0.2	35.6	34.3	80	120.6	0.4	0	0	8	7	0	0	0	13	0	0	0	0	0
cash-flows.row.purchases-of-investments	-320.4	-320	-30	-695	-1271	-510	-1712.2	-2750	-6.7	0	-2.6	-8.8	0	0	0	-0.6	-3.5	0	0	0	0
cash-flows.row.sales-maturities-of-investments	625.03	-0.3	612.7	710.5	742.7	1116.7	1887.2	1992.8	40.3	0.7	0.9	0.9	0.6	0.6	0.6	1.2	0	0	0	0	0
cash-flows.row.other-investing-activites	-14.96	0.9	0.3	7.2	1	-1.6	-16.2	8.2	44.7	0	0	28	0	0.5	0	-13	0.1	5	5	-10	0
cash-flows.row.net-cash-used-for-investing-activites	-104.93	-415.3	460	-52.4	-601.3	524.6	-120.5	-913.2	-102.7	-3.1	-10.4	-1	-27.5	-8.7	-49	-12.4	-12.7	-8.8	-4.1	-24.3	-6.8
cash-flows.row.debt-repayment	-63	-23	-12	-33	-29.2	-366.7	-325.7	-295.3	-607.6	-507.2	-589.6	-434.5	-598.2	-496.5	-485.5	-444	-465.6	-382.4	-309.4	-132	-24.9
cash-flows.row.common-stock-issued	0	0	0	48.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	-48.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-1.66	-1.5	-0.8	-2.4	-3.7	-11.9	-64.5	-14.7	-22.6	-27	-32.2	-28.4	-37.5	-24.7	-18.1	-15.8	-18	-13.8	-11.1	-6.5	-2.1
cash-flows.row.other-financing-activites	50.2	-10.5	9.8	-76.1	-30.5	64.1	393.3	243.7	1732.5	579	604.8	431.5	655.6	536.8	514.8	535.8	493.5	554.4	366.3	228.1	50.8
cash-flows.row.net-cash-used-provided-by-financing-activities	11.54	-5	-3	-111.4	-63.5	-314.5	3	-66.3	1102.3	44.8	-17	-31.4	19.8	15.5	11.3	75.9	9.9	158.2	45.7	89.6	23.8
cash-flows.row.effect-of-forex-changes-on-cash	-0.03	0	0	0	0	0	0	0	0	0	0	-0.1	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	-112.43	-409.3	432.6	-120.4	-533.1	306.5	12	-773.5	1249.8	75.3	-16.7	-28.3	21.5	-2.7	-28.3	24.4	-62.4	51.7	45.1	-8.2	11.8
cash-flows.row.cash-at-end-of-period	2002.99	249	658.3	225.7	346.1	879.3	572.8	560.8	1334.3	84.5	9.2	25.9	54.2	32.7	35.5	63.8	39.4	101.8	50.1	5	13.2
cash-flows.row.cash-at-beginning-of-period	2115.42	658.3	225.7	346.1	879.3	572.8	560.8	1334.3	84.5	9.2	25.9	54.2	32.7	35.5	63.8	39.4	101.8	50.1	5	13.2	1.4
cash-flows.row.operating-cash-flow	-19.01	11	-24.4	43.4	131.7	96.4	129.4	206.1	250.2	33.5	10.6	4.3	29.2	-9.5	9.5	-39.2	-59.7	-97.7	3.5	-73.5	-5.2
cash-flows.row.capital-expenditure	-90.18	-96.2	-123.2	-110.7	-108.4	-160.5	-399.9	-164.6	-181	-3.8	-16.7	-28.2	-28.1	-9.8	-49.7	-13	-9.3	-13.8	-9.1	-14.4	-6.8
cash-flows.row.free-cash-flow	-109.18	-85.2	-147.6	-67.4	23.3	-64.1	-270.4	41.5	69.2	29.7	-6	-24	1.1	-19.4	-40.2	-52.1	-69	-111.5	-5.6	-87.9	-12

Kasumiaruande rida

Innovation Medical Management Co., Ltd. tulud muutusid võrreldes eelmise perioodiga 0.135%. 002173.SZ brutokasum on teatatud 92.21. Ettevõtte tegevuskulud on 126.43, mille muutus võrreldes eelmise aastaga on 3.193%. Kulud amortisatsioonikulud on 106.66, mis on -0.033% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 126.43, mis näitab 3.193% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab 0.642% kasvu võrreldes eelmise aastaga. Tegevustulu on -25.64, mis näitab -0.642% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on -0.536%. Eelmise aasta puhaskasum oli -34.29.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004
income-statement-row.row.total-revenue	802.72	805.6	709.7	711.5	724.2	872.2	1058.9	905.1	762.8	137	183.3	299.2	369	336.9	292.3	284.2	344.1	292	238.6	192.2	151.4
income-statement-row.row.cost-of-revenue	714.85	713.4	679.1	665.4	696.4	803.1	667.4	544.8	467.6	91	112.3	178.5	235.4	224.3	201.1	216.1	240.7	203	164	149.5	116.4
income-statement-row.row.gross-profit	87.87	92.2	30.6	46.2	27.8	69.1	391.5	360.3	295.2	46	71	120.7	133.6	112.6	91.2	68.1	103.4	89	74.7	42.7	35.1
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	25.73	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	9.18	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-8.35	-9.3	83.7	83	85.6	94	-25.5	-26.4	-6	0	2.2	5.3	-1.3	1.5	1	1.1	-0.8	2.1	1.5	0.6	0.8
income-statement-row.row.operating-expenses	122.74	126.4	122.5	125.5	129.4	150.6	142.7	118.9	105.4	85.7	59.8	56.6	54.3	44.7	32.8	34.6	26.9	23.9	17.3	9.5	6.5
income-statement-row.row.cost-and-expenses	837.59	839.8	801.6	790.9	825.8	953.7	810.1	663.7	573	176.7	172.1	235.1	289.6	268.9	233.9	250.7	267.6	226.9	181.2	159	122.9
income-statement-row.row.interest-income	18.57	17.4	14.6	13.1	7.2	6.2	4.7	9	10.6	0.4	1	0.9	0.6	0.6	0.3	0.6	0.4	0.6	0.5	0.2	0.2
income-statement-row.row.interest-expense	3.49	3.6	3.4	6.1	7.6	20.1	35.7	25	44.5	26.6	31.6	28.4	28.1	25	18.3	15.8	18.2	13.9	11.2	6.7	2.3
income-statement-row.row.selling-and-marketing-expenses	9.18	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-8.35	-9.3	-3.7	2.3	-183.4	-1068.9	-151.4	-31.5	-29.9	-24.5	-20.5	-33.1	-36	-29.3	-20.4	-15.9	-22	-12	-16.5	-9.1	-1.6
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-8.35	-9.3	83.7	83	85.6	94	-25.5	-26.4	-6	0	2.2	5.3	-1.3	1.5	1	1.1	-0.8	2.1	1.5	0.6	0.8
income-statement-row.row.total-operating-expenses	-8.35	-9.3	-3.7	2.3	-183.4	-1068.9	-151.4	-31.5	-29.9	-24.5	-20.5	-33.1	-36	-29.3	-20.4	-15.9	-22	-12	-16.5	-9.1	-1.6
income-statement-row.row.interest-expense	3.49	3.6	3.4	6.1	7.6	20.1	35.7	25	44.5	26.6	31.6	28.4	28.1	25	18.3	15.8	18.2	13.9	11.2	6.7	2.3
income-statement-row.row.depreciation-and-amortization	-2.41	106.7	110.3	117.5	62.8	43.8	94.7	92.5	83.3	9	8.2	7.8	7.4	6.2	5.9	5.6	5.2	4.3	3.7	1.4	0.7
income-statement-row.row.ebitda-caps	-29.94	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-27.53	-25.6	-71.6	-107.2	-101.5	-81.5	122.9	236.3	166	-63.9	-11.5	25.8	44.7	37.2	36.9	16.4	55.3	50.9	39.3	23.6	26.1
income-statement-row.row.income-before-tax	-35.87	-35	-75.3	-104.8	-285	-1150.4	97.4	210	159.9	-64.2	-9.3	31	43.3	38.7	37.9	17.6	54.5	53	40.9	24.1	27
income-statement-row.row.income-tax-expense	-0.7	-0.7	-1.4	0.3	29.5	-0.6	67.4	69.2	45.1	1.1	1.6	6.3	4.7	6.5	6.9	4.9	11.6	13.1	10.6	5.7	6.2
income-statement-row.row.net-income	-35.11	-34.3	-73.9	-105.1	-314.4	-1149.8	29.7	140.7	114.7	-65.3	-10.8	23.7	38.2	30	28.8	11.8	37.4	35.4	26.2	15.4	17.2